scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0041-1345(98)01708-4 |
P698 | PubMed publication ID | 10083190 |
P2093 | author name string | K Fukunaga | |
M Otsuka | |||
K Fukao | |||
H Taniguchi | |||
Y Takada | |||
P2860 | cites work | Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats | Q28368149 |
A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
Relationship between early liver graft viability and enzyme activities in effluent preservation solution | Q71770342 | ||
Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats | Q72054035 | ||
Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances | Q72271861 | ||
Cyclic hexapeptide endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETB | Q72425546 | ||
Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver | Q73208997 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 460-461 | |
P577 | publication date | 1999-02-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | Endothelin antagonist improves viability of liver grafts from non-heart-beating donors | |
P478 | volume | 31 |